Measures · D02 in 2015 · Part D · DD1 Drug Plan Customer Service
Appeals Upheld
AppealsDrug PlanSource: Independent Review Entity
- What it measures
- This measure/rating shows how often an Independent Reviewer thought the drug plan’s decision to deny an appeal was fair. This includes appeals made by plan members and out-of-network providers. (This rating is not based on how often the plan denies appeals, but rather how fair the plan is when they do deny an appeal.)
- How it's calculated
- This measure is defined as the percent of IRE confirmations of upholding the plans’ decisions. This is calculated as: [(Number of cases upheld) / (Total number of cases reviewed)] * 100. Total number of cases reviewed is defined all cases received by the IRE during the timeframe and receiving a decision within 20 days after the last day of the timeframe. The denominator is equal to the number of cases upheld, fully reversed, and partially reversed. Dismissed, remanded and withdrawn cases are not included in the denominator. Auto-forward cases are included, as these are considered to be adverse decisions per Subpart M rules. Contracts with no IRE cases reviewed will not receive a score in this measure.
- Data source
- IRE Data were obtained from the IRE contracted by CMS for Part D reconsiderations. The appeals used in this measure are based on the date they were received by the IRE.
- Measurement period
- 01/01/2014 - 06/30/2014
- Better when
- Higher
- Weight
- 1.5 (Measures Capturing Access)
- Star assignment
- Relative Distribution and Clustering
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- —
- Exclusions
Show
Contracts with fewer than 5 cases reviewed by the IRE.
From the 2015 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2015 star distribution
Not rated: No data available (229); Not enough data available (173); Plan too new to be measured (76); Plan not required to report measure (13)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2021 | MA-PD | < 79 % | >= 79 % to < 85 % | >= 85 % to < 89 % | >= 89 % to < 95 % | >= 95 % |
| 2021 | PDP | < 80 % | >= 80 % to < 87 % | >= 87 % to < 93 % | >= 93 % to < 97 % | >= 97 % |
| 2020 | MA-PD | < 71% | ? 71% to < 78% | ? 78% to < 86% | ? 86% to < 94% | ? 94% |
| 2020 | PDP | < 80% | ? 80% to < 84% | ? 84% to < 90% | ? 90% to < 94% | ? 94% |
| 2019 | MA-PD | < 60% | ? 60% to < 69% | ? 69% to < 81% | ? 81% to < 92% | ? 92% |
| 2019 | PDP | < 64% | ? 64% to < 78% | ? 78% to < 89% | ? 89% to < 91% | ? 91% |
| 2018 | MA-PD | < 56% | ? 56% to < 71% | ? 71% to < 79% | ? 79% to < 89% | ? 89% |
| 2018 | PDP | < 61% | ? 61% to < 71% | ? 71% to < 81% | ? 81% to < 92% | ? 92% |
| 2017 | MA-PD | < 47% | ? 47% to < 66% | ? 66% to < 78% | ? 78% to < 88% | ? 88% |
| 2017 | PDP | < 60% | ? 60% to < 66% | ? 66% to < 77% | ? 77% to < 91% | ? 91% |
| 2016 | MA-PD | < 42% | ? 42% to < 60% | ? 60% to < 73% | ? 73% to < 88% | ? 88% |
| 2016 | PDP | < 54% | ? 54% to < 65% | ? 65% to < 76% | ? 76% to < 91% | ? 91% |
| 2015 | MA-PD | < 50% | ? 50% to < 60% | ? 60% to < 72% | ? 72% to < 84% | ? 84% |
| 2015 | PDP | < 48% | ? 48% to < 58% | ? 58% to < 68% | ? 68% to < 78% | ? 78% |
Lowest-scoring contracts, 2015
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S0655 Tufts Health Plan | Point32Health, Inc. | — | 40 | 1 | — | 28 | 0% |
| H5926 Molina Healthcare of Michigan | Molina Healthcare, Inc. | 15,303 | 0 | 1 | — | 72 | 0% |
| H1994 Select Health | Intermountain Health Care, Inc. | 67,364 | 21 | 1 | — | 51 | 1% |
| H3335 Excellus Health Plan, Inc | Lifetime Healthcare, Inc. | 87,150 | 29 | 1 | — | 43 | 1% |
| H5823 Molina Healthcare of Washington, Inc. | Molina Healthcare, Inc. | 13,098 | 33 | 1 | — | 39 | 2% |
| S0522 Symphonix Health Insurance, Inc. | UnitedHealth Group, Inc. | — | 48 | 2 | — | 20 | 2% |
| H3924 Geisinger Gold | Risant Health, Inc. | 24,445 | 38 | 1 | — | 34 | 3% |
| H3351 Excellus Health Plan, Inc | Lifetime Healthcare, Inc. | 172,494 | 38 | 1 | — | 34 | 3% |
| H2944 Humana | Humana Inc. | — | 40 | 1 | — | 32 | 4% |
| H5050 Kaiser Permanente | Kaiser Foundation Health Plan, Inc. | 99,167 | 40 | 1 | — | 32 | 4% |
| E4744 MISSOURI DEPARTMENT OF TRANSPORTATION | Missouri Highways and Transportation Commission | — | 40 | 1 | — | 32 | 4% |
| H3528 ConnectiCare | Molina Healthcare, Inc. | 47,034 | 40 | 1 | — | 32 | 4% |
| S3521 Excellus Health Plan, Inc | Lifetime Healthcare, Inc. | 5,010 | 50 | 2 | — | 18 | 4% |
| S5609 Asuris Northwest Health | Cambia Health Solutions, Inc. | 279 | 50 | 2 | — | 18 | 4% |
| S2505 WINDSOR HEALTH PLAN, INC. | WellCare Health Plans, Inc. | — | 50 | 2 | — | 18 | 4% |
| H1961 Peoples Health | UnitedHealth Group, Inc. | 157,120 | 41 | 1 | — | 31 | 7% |
| H1666 Blue Cross and Blue Shield of NM, TX | Health Care Service Corporation | 15,741 | 43 | 1 | — | 29 | 7% |
| H3954 Geisinger Gold | Risant Health, Inc. | 71,757 | 44 | 1 | — | 28 | 8% |
| H5859 CareOregon Advantage | CareOregon, Inc. | 13,070 | 45 | 1 | — | 27 | 9% |
| H6815 Wellcare | Centene Corporation | 12,439 | 50 | 2 | — | 22 | 9% |
| H9730 Wellcare | Centene Corporation | 35,990 | 50 | 2 | — | 22 | 9% |
| H2224 Molina Healthcare of Massachusetts | Molina Healthcare, Inc. | 10,410 | 50 | 2 | — | 22 | 9% |
| H2230 Blue Cross Blue Shield of Massachusetts | Blue Cross and Blue Shield of Massachusetts, Inc. | 45,136 | 50 | 2 | — | 22 | 9% |
| H5628 Molina Healthcare of Utah & Idaho | Molina Healthcare, Inc. | 16,554 | 50 | 2 | — | 22 | 9% |
| S5916 Regence BlueShield of Idaho and Regence BC BS Utah | Cambia Health Solutions, Inc. | 1,098 | 58 | 3 | — | 10 | 11% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2021 | D03 | Appeals Upheld | 01/01/2019 – 12/31/2019 | 2 | Independent Review Entity |
| 2020 | D03 | Appeals Upheld | 01/01/2018– 12/31/2018 | 1.5 | Independent Review Entity |
| 2019 | D03 | Appeals Upheld | 01/01/2017 – 12/31/2017 | 1.5 | Independent Review Entity |
| 2018 | D03 | Appeals Upheld | 01/01/2016 – 12/31/2016 | 1.5 | Independent Review Entity |
| 2017 | D03 | Appeals Upheld | 01/01/2015 - 12/31/2015 | 1.5 | Independent Review Entity |
| 2016 | D03 | Appeals Upheld | 01/01/2014 - 12/31/2014 | 1.5 | Independent Review Entity |
| 2015 | D02 | Appeals Upheld | 01/01/2014 - 06/30/2014 | 1.5 | Independent Review Entity |